Short answer
CVS Health (CVS) filed an 8-K current report with the SEC on May 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved CVS’s 2026 Incentive Compensation Plan on May 14, 2026.
CVS Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved CVS’s 2026 Incentive Compensation Plan on May 14, 2026
- New plan replaces the expiring 2017 Incentive Compensation Plan
- Applies to awards granted after May 14, 2026
- Continued equity and incentive-award capacity supports executive and employee retention mechanisms
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 13 director nominees reelected for one-year terms, maintaining board continuity
- Ernst & Young ratified as 2026 independent auditor, with 1.117B votes for
- Executive compensation approved on advisory basis, with 976.3M votes for
- 2026 Incentive Compensation Plan approved, authorizing continued equity-based compensation
- Written-consent threshold reduction rejected, limiting shareholders’ ability to act outside meetings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CVS Health 8-K filings
Get the next CVS 8-K as it lands
Follow CVS for push alerts, or ask the research agent what this filing means.